In a preclinical model of nasopharyngeal carcinoma, XIAP maintained stemness by stabilizing the SOX2 protein, extending its half-life by inhibiting autophagic degradation [462]. The gene discussed is SOX2; the disease is nasopharyngeal carcinoma.